New Age Beverages (NBEV) is set to report its Q4 and full-year 2018 results on Friday, March 29 before market opens. Analysts
Tilray Inc.
-(TLRY)
XNAS:TLRY
Tilray posts wider-than-expected Q4 loss
Tilray (TLRY) reported a wider loss in the fourth quarter due to higher operating costs and expenses. For surviving the rising competition
Earnings preview Q4: Amyris likely to benefit from the new cannabinoid deal
Renewables product company Amyris (AMRS) is set to report its fourth quarter and full-year 2018 results on Monday, March 18 after the
Earnings watch: General Mills, FedEx, Conagra, Nike on queue for release
On the economic front, the Federal Reserve is meeting to decide the interest rates changes on March 20 and the European Union
Tilray (TLRY) Q4 earnings preview: All you need to know
Tilray (TLRY), which has been trailing other cannabis stocks since the start of this year, will be put under the scanner as
Tilray rides on successful cannabis harvest in Europe
Tilray’s (TLRY) stock made strong gains early Wednesday after the Canadian marijuana giant said its European arm had a very successful cannabis
Tilray resumes deal spree, signs fifth in 2 months
Tilray Inc. (TLRY) has taken the fusion spree seriously as a new deal has been signed to buy hemp food company Manitoba
Canopy Growth misses Q3 estimates
Canopy Growth (TSX: WEED, NYSE: CGC) reported a loss of CAD0.38 and revenue of CAD83 million, which missed analysts' predictions. Analysts expected Canopy
Investing in pot stocks 101: Here’s what you should know
Marijuana-based stocks are all the rage in the market now. They have even managed to hog the limelight from heavyweight gaming stocks
Q3 Earnings Preview: Canopy Growth likely to continue its recent bullish momentum
Canopy Growth (TSX: WEED, NYSE: CGC) will release its financial results for the third fiscal quarter of 2019 after the markets close
Key comments from Aurora Cannabis (ACB) Q2 2019 earnings conference call
Aurora Cannabis (ACB) on Monday reported a loss of C$238 million in the second quarter of 2019, compared to a profit of
Aurora Cannabis reports a loss of C$238 million for Q2
After a long delay, Aurora Cannabis (ACB) reported its second quarter 2019 results. The company reported a loss of C$238 million compared to
Tilray (TLRY) is reporting Q4 earnings results on March 18. What you need to know
Canadian cannabis giant Tilray (TLRY) is scheduled to report fourth-quarter earnings results on Monday, March 18. Analysts expect the company, which went
Tilray is on a consolidation spree
On the heels of a string of partnership deals, Tilray (TLRY) on Tuesday announced that it was acquiring Canada-based Natura Naturals Holdings
Tilray inks third deal in less than a month, this time with Authentic Brands Group
In its third deal in less than 30 days, Canadian licensed producer Tilray (TLRY) on Tuesday announced a partnership with brand management
Mother sinks as son gains: Today’s bittersweet stock saga
The stock markets often spring up some intriguing storylines. And as markets opened on Wednesday, investors were treated with a bittersweet one.
The cannabis industry is high on deals and partnerships
The marijuana industry may be a relative newbie in the stock markets, but that isn’t stopping it from going on a deal
Thailand legalizes medical use of cannabis, opens up a new region for pot stocks
After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the other two
Budweiser-parent mulls pot-based drinks, inks JV with Tilray
The world’s largest brewery and the parent company of Budweiser, AB InBev (BUD), has given potheads more reasons to cheer ahead of
2018 was the year of healthcare IPOs. Here is why
There were quite a few blockbuster IPOs this year, mostly by tech firms, including Spotify (SPOT), Dropbox (DBX), Elastic (ESTC) and Chinese
Tilray stock falls after Q3 loss widens despite revenue growth
Tilray, Inc. (TLRY) reported a net loss for the third quarter, hurt by higher operating costs. Analysts had forecast a wider loss. Though